PRVA · XBRL financial data

Privia Health Group financial statements, every fiscal year

The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (PRVA's year ends in late December)

In millions of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
General and administrative	256	130	110	126	138
Total operating expenses	1,184	1,376	1,637	1,719	2,089
Operating income (loss)	(217)	(19)	21	17	34
Interest expense	1	1	—	—	—
Income tax expense (benefit)	(28)	(7)	8	11	14
Net income (loss)	(188)	(9)	23	14	23
Earnings per share, basic USD per share	(1.83)	(0.08)	0.20	0.12	0.19
Earnings per share, diluted USD per share	(1.83)	(0.08)	0.19	0.11	0.18
Weighted average shares, basic millions of shares	103	111	117	119	122
Weighted average shares, diluted millions of shares	103	111	125	126	129

Fiscal years (PRVA's year ends in late December)

In millions of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	321	348	390	491	480
Accounts receivable	117	190	291	316	401
Prepaid and other current assets	9	14	21	27	30
Total current assets	447	552	701	835	911
Property and equipment, net	5	3	2	1	1
Right-of-use asset	10	8	7	5	9
Goodwill	128	127	139	142	210
Total assets	686	793	1,000	1,136	1,369
Accounts payable	3	7	8	10	8
Total current liabilities	190	264	387	449	569
Lease liability, non-current	11	8	5	3	7
Total liabilities	236	274	393	452	578
Accumulated deficit	(208)	(217)	(194)	(179)	(156)
Total stockholders' equity	427	499	561	635	737
Total liabilities and equity	686	793	1,000	1,136	1,369
Common shares outstanding (cover page) millions of shares	108	115	119	121	124

Fiscal years (PRVA's year ends in late December)

In millions of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(188)	(9)	23	14	23
Stock-based compensation	254	67	37	57	71
Depreciation and amortization	2	5	7	7	10
Net cash from operating activities	55	47	81	109	163
Purchases of property and equipment	1	0	0	—	—
Net cash from investing activities	(33)	(0)	(43)	(12)	(182)
Net cash from financing activities	214	(20)	4	4	7
Net change in cash	236	27	42	102	(11)

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Privia Health Group	446	657	29*	127.8M	—	Q3 FY26 10-QSep 30, 2026
GeneDx Holdings	60	114	(29)*	29.8M	4.6 quarters	Q2 FY26 10-QJun 30, 2026
Omada Health	222	88	4*	61.2M	—	Q2 FY26 10-QJun 30, 2026
Pennant Group	18	302	25*	35.1M	—	Q3 FY26 10-QSep 30, 2026
LifeStance Health Group	226	435	100*	382.1M	—	Q2 FY26 10-QJun 30, 2026
U S Physical Therapy	25	214	34*	14.9M	—	Q2 FY26 10-QJun 30, 2026
Talkspace	39	62	11*	165.8M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.